Arimiplex

AXIOLABS ARIMIPLEX

Arimiplex, manufactured by Axiolabs, is an aromatase inhibitor containing Anastrozole 1 mg. It is designed to modulate estrogen levels, primarily in the context of hormone-related conditions and steroid cycles.

DRUG COMPOSITION

Each Arimiplex tablet contains Anastrozole 1 mg.

PHARMACEUTICAL FORM

Arimiplex is formulated as oral tablets, ensuring convenient and precise dosing.

PHARMACEUTICAL GROUP AND ATC CODE

Pharmaceutical group: Antineoplastic and immunomodulating agents, enzyme inhibitors. ATC code: L02BG03 - Anastrozole.

PHARMACOLOGICAL PROPERTIES

Anastrozole is a non-steroidal aromatase inhibitor, effectively reducing the conversion of androgens to estrogens. This property is particularly valuable in hormone-responsive conditions and during anabolic steroid cycles to prevent estrogen-related side effects.

PROFILE

• Chemical name: 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile)
• Chemical formula: C17H19N5
• Percentage of anabolic activity: Not a steroid
• Percentage of androgenic activity: Not a steroid
• Active half life: Approximately 46 hours
• Recommended dosage: 1 mg per day for breast cancer; may vary in other applications
• Acne: Not reported
• Bloating (water retention): Not reported
• HBR: Low
• Hepatic toxicity: Rare
• Aromatization: Inhibits aromatase, reducing estrogen conversion

THERAPEUTICAL INDICATIONS

Arimiplex is indicated in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is also utilized in bodybuilding settings to control estrogen levels during steroid cycles.

DOSES AND METHOD OF ADMINISTRATION

The typical dosage for Arimiplex in breast cancer treatment is 1 mg per day. In bodybuilding, doses may vary from 0.25 mg to 1 mg every other day, depending on individual needs and the compounds used in the cycle.

CYCLE/STACKING

Solo cycle:

• Arimiplex solo cycles are uncommon due to its primary use in combination with anabolic steroids. However, a standalone cycle might involve 0.5 mg every other day for estrogen control.

Cutting cycle:

• Arimiplex 0.5 mg every other day + Testaplex P 100 mg every other day for an 8-week cutting cycle.

Bulking cycle:

• Arimiplex 1 mg every other day + Equiplex 400 mg per week for a 12-week bulking cycle.

POST CYCLE THERAPY

Post-cycle therapy with Arimiplex may involve a gradual reduction in dosage over a few weeks, accompanied by monitoring hormone levels to restore natural production.

SIDE EFFECTS

Possible side effects include joint pain, hot flashes, and mood disturbances. Long-term use may impact bone mineral density, requiring monitoring.

CONTRAINDICATIONS

Arimiplex is contraindicated in individuals with hypersensitivity to Anastrozole, premenopausal women, and those with severe hepatic impairment.

OVERDOSE

In case of overdose, symptomatic and supportive measures are advised. There is no specific antidote for Anastrozole.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Regular monitoring of bone health and lipid profiles is recommended during prolonged use. Consultation with a healthcare professional is essential.

INTERACTIONS WITH OTHER DRUGS

Arimiplex may interact with medications that affect liver enzymes. Inform healthcare providers of all current medications.

PRESENTATION, PACKAGING

1 mg per tablet, 50 tablets in sachet.

STORAGE

Store Arimiplex in a cool, dry place, away from direct sunlight.

LEGAL STATUS

Arimiplex is often available only by prescription and is subject to legal regulations. Its use for non-medical purposes may be subject to legal restrictions depending on the country or region.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Axiolabs
Europe

EXTERNAL LINKS

• Anastrozole Wiki, wikipedia.org
• Anastrozole Uses, Side Effects & Warnings, drugs.com
• Anastrozole Oral: Uses, Side Effects, Interactions, Pictures, webmd.com.